当前位置:
X-MOL 学术
›
Lancet Diabetes Endocrinol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2022-05-18 , DOI: 10.1016/s2213-8587(22)00134-6 Olivier Chabre 1 , Marie Muller 2 , Justine Cristante 1 , Jean-Luc Cracowski 3 , Emmanuel Gay 4
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2022-05-18 , DOI: 10.1016/s2213-8587(22)00134-6 Olivier Chabre 1 , Marie Muller 2 , Justine Cristante 1 , Jean-Luc Cracowski 3 , Emmanuel Gay 4
Affiliation
Abstract not available
中文翻译:
Osilodrostat 治疗库欣病:疗效、稳定性和持久性
摘要不可用
更新日期:2022-05-20
中文翻译:
Osilodrostat 治疗库欣病:疗效、稳定性和持久性
摘要不可用